A common deletion at BAK1 reduces enhancer activity and confers risk of intracranial germ cell tumors.
Sonehara K, Kimura Y, Nakano Y, Ozawa T, Takahashi M, Suzuki K, Fujii T, Matsushita Y, Tomiyama A, Kishikawa T, et al. Nat Commun. 2022 Aug 2; 13(1):4478. Epub 2022 Aug 2.